跳至主要内容
临床试验/NCT06108908
NCT06108908招募中不适用

Influence of Inhaler Compliance on the Treatment of Asthma Patients

Taipei Medical University Hospital1 个研究点 分布在 1 个国家目标入组 150 人开始时间: 2019年8月14日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
150
试验地点
1
主要终点
compliance ratio

研究概览

简要总结

The major goal of "Influence of Inhaler Compliance on the Treatment of Asthma Patients" is to explore compliance rate outcome in adult asthmatic patients (20-80 years old) with mild to moderate persistent asthma according to American Thoracic Society (ATS) definition and diagnosis. The major endpoints include:

  1. To increase the adherence rate of treatment by reminder intervention with correctly monitor patients' adherence rate by Asthma Supportive Kits
  2. Eventually achieve best asthma care and management.

All participants will use Asthma Supportive Kits for 24 weeks and return visit on week 5, 12, 24. Based on collected data, the study compares intervention and control group to see if active reminder intervention may effectively alter compliance rate, and corresponding outcomes, e.g., asthma control status, acute exacerbation events.

详细描述

  1. Upon enrollment, the all patients will be educated and equipped with asthma supportive kits, which is a electronic device attaches to an MDI medicine.
  2. The asthma supportive kit registers every puff taken when the patient uses his/her MDI. The records are monitored by study nurses and calculated compliance ratio on rolling basis.
  3. By enrollment, the patient is RANDOMLY assigned to Intervention and Control group. For the Intervention group in each study phases, when the given compliance ratio drops below 80% (as monitored by asthma supportive kit), the study nurse will actively engage to remind on medicine taking. For the Control group, the compliance ratio is calculated but to active engagement is applied.
  4. All the patients adheres with regular asthma treatment mechanism, regardless to group assigned.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
20 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adult asthmatic patients (20-80 years old)
  • With mild to moderate persistent asthma according to ATS definition and diagnosis
  • Willing to use Budesonide+Formoterol.
  • Adequately use inhaler
  • Without evident intentional non-adherence
  • Agree asthma is a common and potentially serious chronic disease
  • Willing to sign Informed Consent Form

排除标准

  • Inadequately use inhaler
  • Disagree asthma is a common and potentially serious chronic disease
  • With uncontrolled systemic diseases, such as hypertension, heart failure, renal failure, de-compensated liver cirrhosis, etc.;

结局指标

主要结局

compliance ratio

时间窗: 28 day

Compliance Ratio: 1. the Compliance Ratio evaluates the ratio of days which the patient is taking equal (or greater than) puffs of medicine as instructed by physician with the past 28-days. 2. the outcome ratio ranges from 0% (none of days is taking correct amount) to 100% (all past 28 days were taking correct amount).

Asthma Control Test Score

时间窗: 28 day

Asthma Control Test (ACT) Score: 1. the ACT is a patient self-administrated tool for identifying those with poorly controlled asthma; 2. the test includes 5 items to recall past 4-week symptoms and daily functioning; 3. The scores range from 5 as poorly controlled to 25 as completely controlled of asthma

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Influence of Inhaler Compliance on the Treatment of... | 临床试验